Hints from the Health Department. Leaflet from the archive of the Society of Medical Officers of Health. Credit: Wellcome Collection, London
[Report of the Medical Officer of Health for London County Council]
This page requires JavaScript
Table (i)
Age | Principal cause of defective vision | Total | |||
---|---|---|---|---|---|
Cataract | Glaucoma | Retrolental fibroplasia | Oilier conditions | ||
1 | — | — | 7 | ||
5-15 years | — | 1 | — | 1 | 2 |
16-64 years | 20 | 17 | — | 168 | 205 |
65-74 years | 60 | 31 | — | 143 | 234 |
75 years and over | 181 | 50 | — | 312 | 543 |
Age not known | 2 | — | — | — | 2 |
264 | 99 | — | 631 | 994 | |
(b) No. recommended to obtain treatment | 177 | 77 | 338 | 592 | |
67.0 | 77.8 | — | 53.6 | 59.6 |
Table (ii)
No. of patients examined | Treatments recommended | Optical | Hospital supervision | |||||
---|---|---|---|---|---|---|---|---|
None | Medical | Surgical | ||||||
Early | Later | if general condition permits | ||||||
Cataract | 264 | 87 | 20 | 40 | 31 | 23 | 15 | 75 |
Glaucoma | 100 | 22 | 22 | 1 | 1 | — | 2 | 57 |
Retrolental fibroplasia | — | — | — | — | — | — | — | — |
Other conditions | 630 | 293 | 72 | 16 | 16 | 10 | 43 | 240 |
TOTAL | 994 | 402 | 114 | 57 | 48 | 33 | 60 | 372 |
Persons recommended to obtain treatment are re-examined at intervals after the
initial registration. The number of persons re-examined for this reason in 1958 is shown
in Table (iii).
Table (iii)
Principal cause of defective vision | Total | ||||
---|---|---|---|---|---|
Cataract | Glaucoma | Retrolental fibroplasia | Other conditions | ||
No. of persons re-examined | 207 | 57 | — | 263 | 527 |
No. found to have had treatment | 151 | 43 | — | 177 | 371 |
Percentage treated | 72.9 | 75.4 | — | 67.3 | 70.4 |
As a consequence of successful treatment, 15 persons previously registered as blind
were found, on re-examination, to be partially-sighted and 5 persons previously
certified as blind or partially-sighted were found to be improved to such an extent as
no longer to justify registration.
Figures for ophthalmia neonatorum are given on page 20.